Tysabri 300 MG per 15 ML Injection
- RxCUI
- 603541
- RxNorm name
- Tysabri 300 MG per 15 ML Injection
- Display name
- Tysabri 300 MG per 15 ML Injection
- Full name
- Tysabri 300 MG per 15 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125104 | Tysabri | natalizumab | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYSABRI | NATALIZUMAB | Biogen Inc. | c5fdde91-1989-4dd2-9129-4f3323ea2962 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | 603541 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c5fdde91-1989-4dd2-9129-4f3323ea2962 | Tysabri 300 MG per 15 ML Injection | SY | 47 | These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004 | 20250321 |
| c5fdde91-1989-4dd2-9129-4f3323ea2962 | 15 ML natalizumab 20 MG/ML Injection [Tysabri] | SBD | 47 | These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004 | 20250321 |
| c5fdde91-1989-4dd2-9129-4f3323ea2962 | Tysabri 300 MG in 15 ML Injection | PSN | 47 | These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004 | 20250321 |
| c5fdde91-1989-4dd2-9129-4f3323ea2962 | 15 ML Tysabri 20 MG/ML Injection | SY | 47 | These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004 | 20250321 |